References
- Feigin VL. Stroke epidemiology in the developing world. Lancet365, 2160–2161 (2005).
- National Collaborating Centre for Chronic Conditions. Stroke: Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). Royal College of Physicians, London, UK (2008).
- Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet371, 1612–1623 (2008).
- National Collaborating Centre for Chronic Conditions. Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care. Royal College of Physicians, London, UK (2006).
- Kimura K, Iguchi Y, Shibazaki K, Iwanaga T, Yamashita S, Aoki J. IV t-PA therapy in acute stroke patients with atrial fibrillation. J. Neurol. Sci.276, 6–8 (2009).
- NINDS t-PA Stroke Study Group. Generalised efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke28, 2119–2125 (1997).
- NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N. Engl. J. Med.333, 1581–1587 (1995).
- NINDS rt-PA Stroke Trial Investigators and Coordinators. A systems approach to immediate evaluation and management of hyperacute stroke: experience at 8 centers and implications for community practice and patient care. Stroke28, 1530–1540 (1997).
- The NINDS rt-PA Stroke Study Group. Effect of rt-PA on ischemic stroke lesion by computed tomography. Stroke31, 2912–2919 (2000).
- Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA Stroke trials. Lancet363, 768–774 (2004).
- Fagan S, Morgenstern L, Petitta A et al.; and NINDS rt-PA Stroke Study Group. Cost–effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology50, 883–890 (1998).
- Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke35, 151–156 (2004).
- Zanerle A, Kiechl S, Spiegel M et al. Recanalization after thrombolysis in stroke patients: predictors and prognostic implications. Neurology68, 39–44 (2007).
- Molina CA, Montaner J, Arenillas JF, Ribo M, Rubiera M, Alvarez-Sabin J. Differential pattern of tissue plasminogen activator – induced proximal middle cerebral artery recanalization among stroke subtypes. Stroke35, 486–490 (2004).
- Kimura K, Iguchi Y, Yamashita S, Shibazaki K, Kobayashi K, Inoue T. Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke. J. Neurol. Sci.267, 57–61 (2008).
- Frankel MR, Morgenstern LB, Kwiatkowski T et al. Predicting prognosis after stroke: a placebo group analysis from the national institute of neurological disorders and stroke rt-PA stroke trial. Neurology55, 952–959 (2000).
- Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke35, 147–150 (2004).
- Yamaguchi T, Mori E, Minematsu K et al.; Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke37, 1810–1815 (2006).
- Hughes M, Lip GY; Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb. Haemost.99, 295–304 (2008).
- Singer DE, Albers GW, Dalen J et al. Antithrombotic therapy in atrial fibrillation: American College of chest physicians evidence-based clinical practice guidelines (8th edition). Chest133, 546S–592S (2008).
- Stroke Risk in Atrial Fibrillation Working Group. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke39, 1901–1910 (2008).
- Partington SL, Abid S, Teo K, Oczkowski W, O’Donnell MJ. Pre-admission warfarin use in patients with acute ischaemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy. Thromb. Res.120, 663–669 (2007).
- Glazer NL, Dublin S, Smith NL et al. Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch. Intern. Med.167, 246–252 (2007).